Thyrocare Technologies Jumps Over 21% in a Week After Robust Q4 Performance

remained in strong momentum during the week ended 8 May 2026, with the stock rallying over 21.5% on a weekly basis. The stock extended gains for the fifth consecutive session on Friday, 8 May 2026, rising as much as 11.74% intraday after its Q4 earnings announcement before closing 3.36% higher. The rally followed a strong quarterly performance from the diagnostics company. Net profit jumped to Rs 47 crore compared with Rs 22 crore a year ago. Revenue increased to Rs 224 crore from Rs 187 crore, while EBITDA rose to Rs 75 crore versus Rs 58 crore in the corresponding quarter last year. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.